Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

380 ARTÍCULOS , VIENDO DEL 361 AL 375

Novel dual GLP-1/GIP receptor agonists show neuroprotective effects in Alzheimer's and Parkinson's disease models

Hölscher C.

Neuropharmacology. 2018 Jul 1;136(Pt B):251-259. doi: 10.1016/j.neuropharm.2018.01.040. Epub 2018 Jan 31.

Evaluation of the safety, tolerability, and efficacy of pimavanserin versus placebo in patients with Alzheimer's disease psychosis: a phase 2, randomised, placebo-controlled, double-blind study

Ballard C, Banister C, Khan Z, Cummings J, Demos G, Coate B, Youakim JM, Owen R, Stankovic S; ADP Investigators.

Lancet Neurol. 2018 Mar;17(3):213-222. doi: 10.1016/S1474-4422(18)30039-5.

Current Limitations in the Treatment of Parkinson's and Alzheimer's Diseases: State-of-the-Art and Future Perspective of Polymeric Carriers

Tonda-Turo C, Origlia N, Mattu C, Accorroni A, Chiono V.

Curr Med Chem. 2018;25(41):5755-5771. doi: 10.2174/0929867325666180221125759.

Elucidating the Structures of Amyloid Oligomers with Macrocyclic β-Hairpin Peptides: Insights into Alzheimer's Disease and Other Amyloid Diseases

Kreutzer AG, Nowick JS.

Acc Chem Res. 2018 Mar 20;51(3):706-718. doi: 10.1021/acs.accounts.7b00554. Epub 2018 Mar 6.

Role of Plant-Derived Flavonoids and Their Mechanism in Attenuation of Alzheimer's and Parkinson's Diseases: An Update of Recent Data

Hussain G, Zhang L, Rasul A, Anwar H, Sohail MU, Razzaq A, Aziz N, Shabbir A, Ali M, Sun T.

Molecules. 2018 Apr 2;23(4):814. doi: 10.3390/molecules23040814.

Impact of aging, Alzheimer's disease and Parkinson's disease on the blood-brain barrier transport of therapeutics

Pan Y, Nicolazzo JA.

Adv Drug Deliv Rev. 2018 Oct;135:62-74. doi: 10.1016/j.addr.2018.04.009. Epub 2018 Apr 14.

A Systematic Review and Meta-Analysis of the Effectiveness of Acetylcholinesterase Inhibitors and Memantine in Treating the Cognitive Symptoms of Dementia

Knight R, Khondoker M, Magill N, Stewart R, Landau S.

Dement Geriatr Cogn Disord. 2018;45(3-4):131-151. doi: 10.1159/000486546. Epub 2018 May 7.

Stem Cell Therapies for Neurodegenerative Diseases

Sugaya K, Vaidya M.

Adv Exp Med Biol. 2018;1056:61-84. doi: 10.1007/978-3-319-74470-4_5.

Association of Tea Consumption with Risk of Alzheimer's Disease and Anti-Beta-Amyloid Effects of Tea

Polito CA, Cai ZY, Shi YL, Li XM, Yang R, Shi M, Li QS, Ma SC, Xiang LP, Wang KR, Ye JH, Lu JL, Zheng XQ, Liang YR.

Nutrients. 2018 May 22;10(5):655. doi: 10.3390/nu10050655.

Beneficial Effects of Green Tea Catechins on Neurodegenerative Diseases

Pervin M, Unno K, Ohishi T, Tanabe H, Miyoshi N, Nakamura Y.

Molecules. 2018 May 29;23(6):1297. doi: 10.3390/molecules23061297.

Flavonoids as Therapeutic Agents in Alzheimer's and Parkinson's Diseases: A Systematic Review of Preclinical Evidences

de Andrade Teles RB, Diniz TC, Costa Pinto TC, de Oliveira Júnior RG, Gama E Silva M, de Lavor ÉM, Fernandes AWC, de Oliveira AP, de Almeida Ribeiro FPR, da Silva AAM, Cavalcante TCF, Quintans Júnior LJ, da Silva Almeida JRG.

Oxid Med Cell Longev. 2018 May 10;2018:7043213. doi: 10.1155/2018/7043213. eCollection 2018.

Mitochondrial abnormalities in Parkinson's disease and Alzheimer's disease: can mitochondria be targeted therapeutically?

Macdonald R, Barnes K, Hastings C, Mortiboys H.

Biochem Soc Trans. 2018 Aug 20;46(4):891-909. doi: 10.1042/BST20170501. Epub 2018 Jul 19.

[Sleep and wakefulness disorders in neurodegenerative diseases]

Yakovleva OV, Poluektov MG, Levin OS, Lyashenko EA.

Zh Nevrol Psikhiatr Im S S Korsakova. 2018;118(4. Vyp. 2):83-91. doi: 10.17116/jnevro20181184283.

Neuroprotective Role of Phytochemicals

Velmurugan BK, Rathinasamy B, Lohanathan BP, Thiyagarajan V, Weng CF.

Molecules. 2018 Sep 27;23(10):2485. doi: 10.3390/molecules23102485.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias